Ventyx Biosciences Statistics
Total Valuation
VTYX has a market cap or net worth of $86.07 million. The enterprise value is -$156.08 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
VTYX has 71.13 million shares outstanding. The number of shares has increased by 16.97% in one year.
Current Share Class | 71.13M |
Shares Outstanding | 71.13M |
Shares Change (YoY) | +16.97% |
Shares Change (QoQ) | +0.20% |
Owned by Insiders (%) | 4.56% |
Owned by Institutions (%) | 62.78% |
Float | 49.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.34 |
P/TBV Ratio | 0.34 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.97, with a Debt / Equity ratio of 0.04.
Current Ratio | 17.97 |
Quick Ratio | 17.09 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.27% and return on invested capital (ROIC) is -35.60%.
Return on Equity (ROE) | -54.27% |
Return on Assets (ROA) | -33.48% |
Return on Invested Capital (ROIC) | -35.60% |
Return on Capital Employed (ROCE) | -56.28% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.65M |
Employee Count | 82 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.16% in the last 52 weeks. The beta is 0.58, so VTYX's price volatility has been lower than the market average.
Beta (5Y) | 0.58 |
52-Week Price Change | -79.16% |
50-Day Moving Average | 1.64 |
200-Day Moving Average | 2.14 |
Relative Strength Index (RSI) | 29.31 |
Average Volume (20 Days) | 733,518 |
Short Selling Information
The latest short interest is 6.91 million, so 9.71% of the outstanding shares have been sold short.
Short Interest | 6.91M |
Short Previous Month | 6.67M |
Short % of Shares Out | 9.71% |
Short % of Float | 13.93% |
Short Ratio (days to cover) | 8.76 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -148.45M |
Pretax Income | -171.30M |
Net Income | -135.12M |
EBITDA | -148.18M |
EBIT | -148.45M |
Earnings Per Share (EPS) | -$1.97 |
Full Income Statement Balance Sheet
The company has $217.32 million in cash and $10.79 million in debt, giving a net cash position of $242.15 million or $3.40 per share.
Cash & Cash Equivalents | 217.32M |
Total Debt | 10.79M |
Net Cash | 242.15M |
Net Cash Per Share | $3.40 |
Equity (Book Value) | 254.05M |
Book Value Per Share | 3.57 |
Working Capital | 216.85M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$130.87 million and capital expenditures -$241,000, giving a free cash flow of -$131.11 million.
Operating Cash Flow | -130.87M |
Capital Expenditures | -241,000 |
Free Cash Flow | -131.11M |
FCF Per Share | -$1.84 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |